Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[EGFR gene mutation statuses in advanced non-small cell lung cancer patients and their influence on effect of gefitinib].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Sept 2012

Zhong Wei, Wang Mengzhao, Li Longyun, Xia Ying, Chen Minjiang, Zhang Li, Zhao Jing

Abstract excerpt

BACKGROUND: It has been proven that the status of epidermal growth factor receptor (EGFR) gene mutation was related to effects of gefitinib in patients with advanced non-small cell lung cancer (NSCLC). The aim of this study is to reports distribution of EGFR gene mutations in advanced NSCLC and t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Lung Neoplasms

Share to Quinazolines

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 22989454
DOI: 10.3779/j.issn.1009-3419.2012.09.03
PMCID: PMC5999860

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22989454-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[EGFR gene mutation statuses in advanced non-small cell lung cancer patients and their influence on effect of gefitinib].PMID 22989454Read ↗

[Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer].Semantic proximity Read ↗

[EGFR mutations in patients with advanced NSCLC].Semantic proximity Read ↗

[EGFR gene mutation status among lung cancer patients in China].Semantic proximity Read ↗

The role of mutation status of the epidermal growth factor receptor gene in advanced non-small cell lung cancer.Semantic proximity Read ↗

[Influence of mutations in epidermal growth factor receptor gene on growth, metastasis and survival rate of non-small cell lung carcinoma].Semantic proximity Read ↗

[Detection and evaluation of EGFR mutation status in serum of patients with advanced non-small cell lung cancer treated with EGFR-TKIs].Semantic proximity Read ↗

[Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].Semantic proximity Read ↗

[Clinical observation of EGFR-TKI as a first-line therapy on advanced non-small cell lung cancer].Semantic proximity Read ↗

[Exon-dependent Subgroup-analysis of the Non-interventional REASON-Study: PFS and OS in EGFR-mutated NSCLC Patients Treated with Gefitinib or Chemotherapy].Semantic proximity Read ↗

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancerSemantic proximity Read ↗

Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.